BE621147A - - Google Patents
Info
- Publication number
- BE621147A BE621147A BE621147DA BE621147A BE 621147 A BE621147 A BE 621147A BE 621147D A BE621147D A BE 621147DA BE 621147 A BE621147 A BE 621147A
- Authority
- BE
- Belgium
- Prior art keywords
- aggregates
- cellulose
- sep
- crystallites
- polymerization
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L1/00—Compositions of cellulose, modified cellulose or cellulose derivatives
- C08L1/02—Cellulose; Modified cellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BE621147T |
Publications (1)
Publication Number | Publication Date |
---|---|
BE621147A true BE621147A (xx) |
Family
ID=3875687
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BE621147D BE621147A (xx) |
Country Status (2)
Country | Link |
---|---|
BE (1) | BE621147A (xx) |
FR (1) | FR2695M (xx) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2007475A1 (xx) * | 1968-04-18 | 1970-01-09 | Garland Richard Brown | |
EP0001247A1 (en) * | 1977-09-14 | 1979-04-04 | Kanebo, Ltd. | Pharmaceutical preparation containing nifedipine and a method for producing the same. |
EP0237506A1 (en) * | 1986-02-14 | 1987-09-16 | Lejus Medical Aktiebolag | Pharmaceutical composition |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU508480B2 (en) * | 1977-04-13 | 1980-03-20 | Asahi Kasei Kogyo Kabushiki Kaisha | Microcrystalline cellulose excipient and pharmaceutical composition containing thesame |
-
0
- BE BE621147D patent/BE621147A/fr unknown
-
1962
- 1962-07-30 FR FR905514A patent/FR2695M/fr active Active
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2007475A1 (xx) * | 1968-04-18 | 1970-01-09 | Garland Richard Brown | |
EP0001247A1 (en) * | 1977-09-14 | 1979-04-04 | Kanebo, Ltd. | Pharmaceutical preparation containing nifedipine and a method for producing the same. |
EP0237506A1 (en) * | 1986-02-14 | 1987-09-16 | Lejus Medical Aktiebolag | Pharmaceutical composition |
Also Published As
Publication number | Publication date |
---|---|
FR2695M (fr) | 1964-08-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US3146168A (en) | Manufacture of pharmaceutical preparations containing cellulose crystallite aggregates | |
EP1873196B1 (en) | Porous cellulose aggregate and molding composition thereof | |
DE69231499T2 (de) | Zusammensetzung auf der basis von mikrokristalliner zellulose für die herstellung von kugelförmigen teilchen | |
CA2261092A1 (fr) | Additivation de nanofibrilles de cellulose avec de la cellulose carboxylee a bas degre de substitution | |
JPS6090234A (ja) | 固形物コーティング用フイルム形成性組成物 | |
FR2484834A1 (fr) | Composition pharmaceutique contenant des sels d'aluminium de l'ibuprofene | |
FR2671353A1 (fr) | Colles pour papiers muraux a base de matieres polymeres adhesives hydrosolubles. | |
LU85850A1 (fr) | Compositions pour les soins des voies respiratoires | |
NAGPAL et al. | Extraction of gum from Abelmoschus esculentus: Physicochemical peculiarity and antioxidant prepatent | |
WO2004043166A1 (fr) | Utilisation de maltodextrines branchees comme liants de granulation | |
CA2814184C (fr) | Poudre de polysaccharide et de polyol, comprimable et de haute viscosite | |
CA2287485A1 (fr) | Nouveau procede d'obtention de microspheres et les produits ainsi realises | |
BE621147A (xx) | ||
FR2529784A1 (fr) | Medicament a liberation retardee contenant du 1-(p-(isopropylthio)-phenyl)-2-octylamino-1-propanol | |
FR2460666A1 (fr) | Procede pour preparer, a l'aide de polysaccharides du soja, des compositions pharmaceutiques a desagregation facile | |
JP5903250B2 (ja) | 徐放性組成物 | |
Momoh et al. | Biochemical, rheological and hydrophile-lipophile balance (HLB) evaluation of Archachatina marginata (snail) mucin extract for possible nutraceutical and nano biopharmaceutical applications | |
WO2020012140A1 (fr) | Excipient sous forme solide comprenant un ensemble de fibres alimentaires végétales non modifiées chimiquement | |
EP1582222B1 (fr) | Tensioactifs sous forme de poudre utilisables dans des comprimés ou des gélules ; procédé de préparation et compositions les contenant | |
BE838506R (fr) | Comprimes contenant une combinaison d'une 2,4-diaminopyrimidine avec un sulfonamide | |
Nwachukwu et al. | Evaluation of Modified Pennisetum glaucum Starch as a Suspending Agent in Metronidazole Benzoate Suspension:(TJPS-2020-0241. R1) | |
Kadoli et al. | Study of Binding Efficiency of Tapioca Starch using Iornoxicam as a Model Drug | |
EP1409002B9 (fr) | Spheroides a base d'adsorbats d'extraits vegetaux et procede de preparation | |
CH650150A5 (fr) | Composition pharmaceutique renfermant du cromoglycate de sodium. | |
Nnamani et al. | EFFECTIVENESS OF CO-PROCESSED ZEA MAYS HUSK CELLULOSE AND SODIUM CARBOXYMETHYLCELLULOSE AS A SUSPENDING AGENT IN INDOMETHACIN DRY SYRUP. |